195 related articles for article (PubMed ID: 31481496)
1. Serine-Phosphorylated STAT3 Promotes Tumorigenesis via Modulation of RNA Polymerase Transcriptional Activity.
Balic JJ; Garama DJ; Saad MI; Yu L; West AC; West AJ; Livis T; Bhathal PS; Gough DJ; Jenkins BJ
Cancer Res; 2019 Oct; 79(20):5272-5287. PubMed ID: 31481496
[TBL] [Abstract][Full Text] [Related]
2. Constitutive STAT3 Serine Phosphorylation Promotes Helicobacter-Mediated Gastric Disease.
Balic JJ; Saad MI; Dawson R; West AJ; McLeod L; West AC; D'Costa K; Deswaerte V; Dev A; Sievert W; Gough DJ; Bhathal PS; Ferrero RL; Jenkins BJ
Am J Pathol; 2020 Jun; 190(6):1256-1270. PubMed ID: 32201262
[TBL] [Abstract][Full Text] [Related]
3. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis.
Judd LM; Bredin K; Kalantzis A; Jenkins BJ; Ernst M; Giraud AS
Gastroenterology; 2006 Oct; 131(4):1073-85. PubMed ID: 17030178
[TBL] [Abstract][Full Text] [Related]
4. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.
Ernst M; Najdovska M; Grail D; Lundgren-May T; Buchert M; Tye H; Matthews VB; Armes J; Bhathal PS; Hughes NR; Marcusson EG; Karras JG; Na S; Sedgwick JD; Hertzog PJ; Jenkins BJ
J Clin Invest; 2008 May; 118(5):1727-38. PubMed ID: 18431520
[TBL] [Abstract][Full Text] [Related]
5. Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model.
Thiem S; Eissmann MF; Elzer J; Jonas A; Putoczki TL; Poh A; Nguyen P; Preaudet A; Flanagan D; Vincan E; Waring P; Buchert M; Jarnicki A; Ernst M
Cancer Res; 2016 Apr; 76(8):2277-87. PubMed ID: 26837764
[TBL] [Abstract][Full Text] [Related]
6. Clinical Utility of a STAT3-Regulated miRNA-200 Family Signature with Prognostic Potential in Early Gastric Cancer.
Yu L; Wu D; Gao H; Balic JJ; Tsykin A; Han TS; Liu YD; Kennedy CL; Li JK; Mao JQ; Tan P; Oshima M; Goodall GJ; Jenkins BJ
Clin Cancer Res; 2018 Mar; 24(6):1459-1472. PubMed ID: 29330205
[No Abstract] [Full Text] [Related]
7. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation.
Tye H; Kennedy CL; Najdovska M; McLeod L; McCormack W; Hughes N; Dev A; Sievert W; Ooi CH; Ishikawa TO; Oshima H; Bhathal PS; Parker AE; Oshima M; Tan P; Jenkins BJ
Cancer Cell; 2012 Oct; 22(4):466-78. PubMed ID: 23079657
[TBL] [Abstract][Full Text] [Related]
8. The interleukin-6 family cytokine interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development.
Howlett M; Giraud AS; Lescesen H; Jackson CB; Kalantzis A; Van Driel IR; Robb L; Van der Hoek M; Ernst M; Minamoto T; Boussioutas A; Oshima H; Oshima M; Judd LM
Gastroenterology; 2009 Mar; 136(3):967-77. PubMed ID: 19121317
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS
Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-11-driven gastric tumourigenesis is independent of trans-signalling.
Balic JJ; Garbers C; Rose-John S; Yu L; Jenkins BJ
Cytokine; 2017 Apr; 92():118-123. PubMed ID: 28160627
[TBL] [Abstract][Full Text] [Related]
11. Activation of STAT3 signaling is mediated by TFF1 silencing in gastric neoplasia.
Soutto M; Chen Z; Bhat AA; Wang L; Zhu S; Gomaa A; Bates A; Bhat NS; Peng D; Belkhiri A; Piazuelo MB; Washington MK; Steven XC; Peek R; El-Rifai W
Nat Commun; 2019 Jul; 10(1):3039. PubMed ID: 31292446
[TBL] [Abstract][Full Text] [Related]
12. Cytokine signalling via gp130 in gastric cancer.
Howlett M; Menheniott TR; Judd LM; Giraud AS
Biochim Biophys Acta; 2009 Nov; 1793(11):1623-33. PubMed ID: 19665497
[TBL] [Abstract][Full Text] [Related]
13. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
[TBL] [Abstract][Full Text] [Related]
14. Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development.
Hill DG; Yu L; Gao H; Balic JJ; West A; Oshima H; McLeod L; Oshima M; Gallimore A; D'Costa K; Bhathal PS; Sievert W; Ferrero RL; Jenkins BJ; Jones GW
Int J Cancer; 2018 Jul; 143(1):167-178. PubMed ID: 29417587
[TBL] [Abstract][Full Text] [Related]
15. Bidirectional regulation between TMEFF2 and STAT3 may contribute to Helicobacter pylori-associated gastric carcinogenesis.
Sun TT; Tang JY; Du W; Zhao HJ; Zhao G; Yang SL; Chen HY; Hong J; Fang JY
Int J Cancer; 2015 Mar; 136(5):1053-64. PubMed ID: 24996057
[TBL] [Abstract][Full Text] [Related]
16. STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis.
Dawson RE; Deswaerte V; West AC; Tang K; West AJ; Balic JJ; Gearing LJ; Saad MI; Yu L; Wu Y; Bhathal PS; Kumar B; Chakrabarti JT; Zavros Y; Oshima H; Klinman DM; Oshima M; Tan P; Jenkins BJ
Gut; 2022 Aug; 71(8):1515-1531. PubMed ID: 34489308
[TBL] [Abstract][Full Text] [Related]
17. Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism.
Deswaerte V; Nguyen P; West A; Browning AF; Yu L; Ruwanpura SM; Balic J; Livis T; Girard C; Preaudet A; Oshima H; Fung KY; Tye H; Najdovska M; Ernst M; Oshima M; Gabay C; Putoczki T; Jenkins BJ
Cancer Res; 2018 Mar; 78(5):1293-1307. PubMed ID: 29282220
[TBL] [Abstract][Full Text] [Related]
18. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
[TBL] [Abstract][Full Text] [Related]
19. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer.
Wu X; Yang T; Liu X; Guo JN; Xie T; Ding Y; Lin M; Yang H
Tumour Biol; 2016 Apr; 37(4):5493-501. PubMed ID: 26566627
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic inhibition of Jak activity inhibits progression of gastrointestinal tumors in mice.
Stuart E; Buchert M; Putoczki T; Thiem S; Farid R; Elzer J; Huszar D; Waring PM; Phesse TJ; Ernst M
Mol Cancer Ther; 2014 Feb; 13(2):468-74. PubMed ID: 24398427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
